Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Star Scientific, Inc. (NASDAQ: STSI) announced that the Company will formally change its corporate name to Rock Creek Pharmaceuticals, Inc. effective ...
Star Scientific, Inc., (NASDAQ: STSI) announced that the Company has retained Shareholder Intelligence Services, LLC ("ShareIntel"), a provider of...
Star Scientific, Inc. (NASDAQ: STSI) today filed its annual report on Form 10-K with the Securities & Exchange Commission (SEC). In December 2013,...
Star Scientific, Inc., (NASDAQ: STSI) today announced that the Company will host an Analyst and Investor meeting for research analysts, and...
Star Scientific, Inc., (NASDAQ: STSI) announced today that Theodore Jenkins has joined the Company as Vice President, Corporate Strategy and...
Star Scientific, Inc., (NASDAQ: STSI) announced today that its conference call presentation announced on January 2, 2014, will be held at 4 p.m. ET...
Star Scientific, Inc., (NASDAQ: STSI) announced today that the Company will hold a conference call for investors on January 15, 2014, to discuss...
Star Scientific, Inc., (NASDAQ: STSI) announced that today it has entered into a Letter of Intent for a $15 million Credit Facility with Jonnie R....
Star Scientific, Inc. (NASDAQ:STSI) announced the receipt on December 24, 2013, of a warning letter from the U.S. Food and Drug Administration (FDA)...
Star Scientific, Inc., (NASDAQ: STSI) today filed with the Securities and Exchange Commission its Form 10-Q for the quarter ended September 30, 2013. ...
Star Scientific, Inc. (NASDAQ: STSI) today announced that the Company has filed its preliminary proxy statement on Form 14A with the Securities and...
Star Scientific, Inc. (NASDAQ: STSI) and Rock Creek Pharmaceuticals, Inc. announce the publication of a peer-reviewed article reporting results from...
Star Scientific, Inc. (NASDAQ: STSI) announced that the U.S. Patent and Trademark Office ("PTO") issued a Notice of Allowance on September 3, 2013 to ...
Star Scientific, Inc., (NASDAQ: STSI) and its subsidiary, Rock Creek Pharmaceuticals, are pleased to announce that LPGA and World Golf Hall of Fame...
Star Scientific, Inc., (NASDAQ: STSI) today filed with the Securities and Exchange Commission its Form 10-Q for the quarter ended June 30, 2013....
Star Scientific, Inc., (NASDAQ: STSI) today filed with the Securities Exchange Commission its Form 10-Q for the quarter ended March 31, 2013. (Logo:...
Star Scientific, Inc. (NASDAQ: STSI) is proud to congratulate Fred Couples, the Company's first Anatabloc® Brand Ambassador, for being inducted into...
Star Scientific, Inc. (NASDAQ: STSI) announced today that the Company's second cosmetic product, Anatabloc® Revitalizing Facial Serum, is now...
Star Scientific, Inc. (NASDAQ: STSI) is pleased to announce that its Anatabloc® dietary supplement has qualified as an Informed-Sport Registered...
Star Scientific, Inc. (NASDAQ: STSI) is proud to congratulate its Anatabloc® brand ambassadors, Fred Couples and John Isner, for their exceptional...
Paul L. Perito, Esquire, Chairman, President and COO of Star Scientific, Inc. (NASDAQ: STSI), issued the following statement on behalf of Star...
Paul L. Perito, Esquire, Chairman, President, and COO of Star Scientific, Inc. (NASDAQ: STSI), issued the following statement on behalf of Star...
Star Scientific, Inc. (NASDAQ: STSI) today announced that the Company's dietary supplement, Anatabloc®, was selected as a recipient of the annual GNC ...
Star Scientific, Inc. (NASDAQ: STSI), through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Inc., announced today that it has received...
Star Scientific, Inc. (NASDAQ: STSI) today filed its annual financial report on Form 10-K with the Securities & Exchange Commission (SEC). The...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.